These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23408016)

  • 21. Impact of induction therapy on postoperative outcome after extrapleural pneumonectomy for malignant pleural mesothelioma: does induction-accelerated hemithoracic radiation increase the surgical risk?
    Mordant P; McRae K; Cho J; Keshavjee S; Waddell TK; Feld R; de Perrot M
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):433-8. PubMed ID: 27005976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.
    Friedberg JS; Simone CB; Culligan MJ; Barsky AR; Doucette A; McNulty S; Hahn SM; Alley E; Sterman DH; Glatstein E; Cengel KA
    Ann Thorac Surg; 2017 Mar; 103(3):912-919. PubMed ID: 27825687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of care and survival of older patients with malignant pleural mesothelioma.
    Linton A; Blinman P; Kao S; van Zandwijk N
    J Geriatr Oncol; 2019 Jul; 10(4):573-576. PubMed ID: 30917938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes.
    Linton A; Soeberg M; Broome R; Kao S; van Zandwijk N
    Respirology; 2017 Jul; 22(5):978-985. PubMed ID: 28139858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases.
    Clive AO; Wilson P; Taylor H; Morley AJ; de Winton E; Panakis N; Rahman N; Pepperell J; Howell T; Batchelor TJ; Jordan N; Lee YC; Dobson L; Maskell NA
    BMJ Open; 2015 Jan; 5(1):e006673. PubMed ID: 25575875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
    Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
    Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological complete response in malignant pleural mesothelioma patients following induction chemotherapy: Predictive factors and outcomes.
    Lau B; Kumar S; Yan T; Burn J; Kennedy C; McLean J; Boyer M; McCaughan B; Kao S
    Lung Cancer; 2017 Sep; 111():75-78. PubMed ID: 28838403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review.
    Hashimoto K; Okuma Y; Hosomi Y; Hishima T
    BMC Cancer; 2016 Sep; 16(1):718. PubMed ID: 27599565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.
    Elkiran ET; Kaplan MA; Sevinc A; Aksoy S; Demirci U; Seker M; Harputluoglu H; Ozdemir NY; Isik F; Ulas A; Inanc M; Arslan UY; Dogu GG; Isikdogan A; Buyukberber S;
    Med Oncol; 2012 Dec; 29(5):3147-54. PubMed ID: 22722923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma.
    Lim JH; Choi JY; Im Y; Yoo H; Jhun BW; Jeong BH; Park HY; Lee K; Kim H; Kwon OJ; Han J; Ahn MJ; Kim J; Um SW
    PLoS One; 2020; 15(2):e0229299. PubMed ID: 32069313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fast neutron radiotherapy in the treatment of malignant pleural mesothelioma.
    Patel SA; Kusano AS; Truong A; Stelzer KJ; Laramore GE
    Am J Clin Oncol; 2015 Feb; 38(1):47-50. PubMed ID: 25616202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes.
    Baird A; Nasser A; Tanuseputro P; Webber C; Wheatley-Price P; Munro C
    Curr Oncol; 2024 Feb; 31(2):1028-1034. PubMed ID: 38392070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent?
    Lindenmann J; Matzi V; Neuboeck N; Anegg U; Maier A; Smolle J; Smolle-Juettner FM
    Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):237-43. PubMed ID: 23171517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrapleural pneumonectomy for malignant pleural mesothelioma: is this an operation that should now be consigned to history?
    Treasure T
    Future Oncol; 2015; 11(24 Suppl):7-10. PubMed ID: 26638915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group.
    Remon J; Nadal E; Dómine M; Ruffinelli J; García Y; Pardo JC; López R; Cilleruelo A; García-Campelo R; Martín P; Juan O; González-Larriba JL; Provencio M; Olmedo E; Ponce S; Cumplido D; Barenys C; Majem M; Massutti B; Rodriguez-Abreu D; Porta R; Sala MA; Martinez-Kareaga M; Lianes P; Reguart N
    Lung Cancer; 2020 Sep; 147():83-90. PubMed ID: 32682189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial.
    Gunatilake S; Brims FJ; Fogg C; Lawrie I; Maskell N; Forbes K; Rahman N; Morris S; Ogollah R; Gerry S; Peake M; Darlison L; Chauhan AJ
    Trials; 2014 Sep; 15():367. PubMed ID: 25238873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
    Wu TH; Lee LJ; Yuan CT; Chen TW; Yang JC
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):230-236. PubMed ID: 29709339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy.
    Kimura T; Doi Y; Nakashima T; Imano N; Katsuta T; Takahashi S; Kenjo M; Ozawa S; Murakami Y; Nagata Y
    J Radiat Res; 2015 Mar; 56(2):315-24. PubMed ID: 25599996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.
    Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T
    In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.